FDA Expands Flibanserin Approval to Postmenopausal Women With Hypoactive Sexual Desire Disorder
March 24, 2026
The FDA has recently granted expanded approval for flibanserin to t...
Read More
Exercise Demonstrates Moderate Effects for Depression and Anxiety Across the Lifespan
March 19, 2026
A recent meta-meta-analysis examining the effects of structured exe...
Read More
Rethinking Mood Disorder Treatment with Immunometabolic Insights
March 17, 2026
While there are many stimulant and non-stimulant options targeting ...
Read More
Brain Awareness Week: March 16-22, 2026
March 16, 2026
Each March, the global community comes together to celebrate Brain ...
Read More
FDA Accepts New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension
March 9, 2026
In February 2026, Teva Pharmaceuticals announced that the FDA has a...
Read More
Ketogenic Diet Shows Modest Short-Term Benefit in Treatment-Resistant Depression
March 5, 2026
Studies have suggested that a ketogenic diet –a high-fat, low-carbo...
Read More
Long-Term Impact of Cognitive Training on Dementia Risk: 20-Year Outcomes From a Randomized Trial
March 2, 2026
In older adults, cognitive training can facilitate long-term improv...
Read More
Preinjury Antidepressant Use Does Not Appear to Worsen Clinical Outcomes after TBI
February 26, 2026
Concerns have long circulated that serotonergic antidepressants may...
Read More
FDA Approves Milsaperidone for Schizophrenia and Acute Bipolar I Disorder
February 20, 2026
The FDA has approved milsaperidone for the treatment of schizophren...
Read More
Metformin Modestly Reduces BMI in Overweight Youth With Bipolar Disorders
February 18, 2026
Second-generation antipsychotics (SGAs) are first-line pharmacologi...
Read More
Serial Intravenous Ketamine Infusions Not Superior to Usual Inpatient Care for Depression
February 9, 2026
Serial IV ketamine infusions are increasingly used off-label for tr...
Read More
Efficacy and Tolerability of Antipsychotics for Acute Schizophrenia
February 5, 2026
Antipsychotic selection in schizophrenia remains an important, high...
Read More